On 3/7/24, TAT Technologies Ltd (NASDAQ: TATT) stock suffered a major decline of -10.7%, closing at $11.88. Moreover, exceptionally high trading volume at 345% of normal accompanied the decline. The stock has been exceptionally strong […]
MacroGenics Inc (NASDAQ: MGNX) has reported E.P.S. of $-0.75 for its fourth fiscal quarter (ending December 31) versus $0.21 for the same period a year ago. For the latest four quarters through December 31, E.P.S. […]
John Wiley & Sons Inc. (NYSE: WLY) has reported E.P.S. of $-2.08 for its third fiscal quarter (ending January 31) versus $-1.29 for the same period a year ago. For the latest four quarters through […]
HCI Group Inc (NYSE: HCI) has reported E.P.S. of $4.31 for its fourth fiscal quarter (ending December 31) versus $0.18 for the same period a year ago. For the latest four quarters through December 31, […]
Cryo-Cell International Inc (NYSEAMERICAN: CCEL) stock enjoyed a major increase of 10.7% on 3/7/24. The shares closed at $6.10. Moreover, exceptionally high trading volume at 331% of normal accompanied the advance. Relative to the market […]
Burlington Stores Inc (NYSE: BURL) has reported E.P.S. of $3.53 for its fourth fiscal quarter (ending January 31) versus $2.84 for the same period a year ago. E.P.S. were $5.23 for the latest four quarters […]
Avid Bioservices Inc (NASDAQ: CDMO) stock suffered a major decline of -30.6% on 3/7/24. The shares closed at $6.10. Moreover, this decline was accompanied by exceptionally high trading volume at 1183% of normal. The stock […]
BUSINESS Honeywell International Inc. operates as a diversified technology and manufacturing company worldwide. Its Aerospace segment offers auxiliary power units, propulsion engines, integrated avionics, environmental control and electric power systems, engine controls, flight safety, communications, […]
OneSpan Inc (NASDAQ: OSPN) stock enjoyed a major increase of 23.1% on 3/7/24. The shares closed at $11.79. Moreover, this advance was accompanied by exceptionally high trading volume at 915% of normal. The stock has […]
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has reported E.P.S. of $-0.33 for its fourth fiscal quarter (ending December 31) versus $-1.16 for the same period a year ago. For the latest four quarters through December 31, […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research